EX-99.1 2 v472541_ex99-1.htm EXHIBIT 99.1

 

Exhibit 99.1

 

Sapiens Logo notag.jpg

 

 

Sapiens Reports Q2 2017 Financial Results

 

Non-GAAP revenue up 30.4% compared to the second quarter of 2016

 

 

Holon, Israel, August 7, 2017 Sapiens International Corporation, (NASDAQ and TASE: SPNS), a leading global provider of software solutions for the insurance industry, with a growing presence in the financial services sector, and a member of the Formula Group (NASDAQ: FORTY and TASE: FORT), today announced its financial results for the second quarter ended June 30, 2017.

 

Second Quarter Highlights:

 

GAAP revenue of $69.0 million, up 30.2% compared to $53.0 million in the second quarter of 2016.

 

Non-GAAP revenue of $69.2 million, up 30.4% compared to $53.0 million in the second quarter of 2016.

 

GAAP operating loss totaled $3.0 million, compared to operating income of $6.4 million (12.1% operating margin) in the second quarter of 2016. GAAP operating loss for the second quarter of 2017 included $3.9 million in restructuring and cost reduction plan.

 

Non-GAAP operating profit totaled $3.2 million (4.7% operating margin), compared to $7.4 million (14.0% operating margin) in the second quarter of 2016.

 

GAAP net loss attributable to Sapiens' shareholders totaled $3.6 million or $(0.07) per diluted share compared to net income attributable to Sapiens' shareholders of $5.3 million, or $0.11 per diluted share in the second quarter last year.

 

Non-GAAP net income attributable to Sapiens' shareholders totaled $1.9 million or $0.04 per diluted share compared to net income attributable to Sapiens' shareholders of $6.3 million, or $0.13 per diluted share in the second quarter last year.

 

Cash, cash equivalents as of June 30, 2017 were $46.4 million, with total debt of $38.0 million.

 

“Sapiens delivered another quarter of double-digit revenue growth, driven by a mix of organic growth and our recent acquisition of StoneRiver,” said Roni Al-Dor, president and CEO of Sapiens. “We witnessed growth across North America, Europe and South Africa. We reported Non-GAAP operating margin of 4.7% which was higher than our guidance of 3-4%. We believe we are on track for continued improvement in our operational profitability.

 

1

 

 

Al-Dor continued: “We remain very excited about the StoneRiver acquisition and we have made solid steps in combining our two organizations. To date, each StoneRiver division has been fully merged with its peer division at Sapiens, with all of our U.S. P&C activities now in a single group. The StoneRiver and Sapiens sales departments have been integrated, while adding account managers to grow business with existing clients and our marketing departments has been merged into one. All corporate functions and back-office operations, including IT, finance, legal, HR and purchasing, are now also fully integrated. Meanwhile, Sapiens is planning to further leverage our offshore capabilities to drive additional efficiencies and reduce costs throughout the company. Overall, our integration efforts are proceeding according to plan at this time and Sapiens management believes we are on track for the second half of 2017."

 

During the quarter, we implemented restructuring and cost reduction plan in total of $3.9 million dollars. The restructuring and cost reduction plan included: integration of StoneRiver, de-emphasis of non-core activities in APAC and efficiency measures post the halted development project. The cost savings primarily include headcount reductions as well as other cost saving measures. We continue to expect restructuring and cost reduction expenses of up to $5 million for the full year 2017.

 

Al-Dor concluded: “Sapiens is maintaining our guidance for 2017 full year revenues of $265 to $275 million (on a non-GAAP basis). We are also maintaining expectations for operating profit margin 13.5-14.5% in the second half of the year (in each case, on a non-GAAP basis) and our expectations for full-year operating profit margin between 9-10% (on a non-GAAP basis).”

 

Quarterly Results Conference Call

 

Management will host a conference call and webcast on August 7 at 9:30 a.m. Eastern Time (4:30 p.m. in Israel) to review and discuss Sapiens’ results.

 

Please call the following numbers (at least 10 minutes before the scheduled time) to participate:

 

North America (toll-free): + 1-888-407-2553; International: +972-3-918-0685; UK: 0-800-917-5108.

 

2

 

 

The live webcast of the call can be viewed on Sapiens’ website at: http://www.sapiens.com/investors/presentations-and-webcast/

 

If you are unable to join live, a replay of the call will be accessible until August 17, 2017, as follows:

 

North America: 1-866-500-4953; International: +972-3-925-5947.

 

A recorded version of the webcast will also be available via the Sapiens website, for three months at the same location.

 

Non-GAAP Financial Measures

 

This press release contains the following non-GAAP financial measures: non-GAAP revenue, non-GAAP gross profit, non-GAAP operating income, non-GAAP net income attributed to Sapiens shareholders, and non-GAAP basic and diluted earnings per share.

 

Sapiens believes that these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Sapiens' financial condition and results of operations. The Company's management uses these non-GAAP measures to compare the Company's performance to that of prior periods for trend analyses, for purposes of determining executive and senior management incentive compensation and for budgeting and planning purposes. These measures are used in financial reports prepared for management and in quarterly financial reports presented to the Company's board of directors. The Company believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends, and in comparing the Company's financial measures with other software companies, many of which present similar non-GAAP financial measures to investors.

 

Non-GAAP financial measures consist of GAAP financial measures adjusted to exclude: amortization of intangible assets, capitalization of software development, stock-based compensation, compensation related to acquisition, acquisition-related costs, restructuring and cost reduction plan, loss on sales of Marketable Securities and tax adjustment regarding non-GAAP adjustments.

 

Management of the Company does not consider these non-GAAP measures in isolation, or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company's financial statements. In addition, they are subject to inherent limitations, as they reflect the exercise of judgment by management about which expenses and income are excluded or included in determining these non-GAAP financial measures.

 

3

 

 

To compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. Sapiens urges investors to review the reconciliation of its non-GAAP financial measures to the comparable GAAP financial measures, which it includes in press releases announcing quarterly financial results, including this press release, and not to rely on any single financial measure to evaluate the Company's business.

 

Reconciliation tables of the most comparable GAAP financial measures to the non-GAAP financial measures used in this press release are included with the financial tables of this release.

 

The Company defines Adjusted EBITDA as net profit, adjusted for stock-based compensation expense, depreciation and amortization, capitalized of software development costs, compensation expenses related to acquisition, acquisition-related costs, restructuring and cost reduction plan, financial expense (income), provision for income taxes and other income (expenses). These amounts are often excluded by other companies to help investors understand the operational performance of their business.

 

The Company uses Adjusted EBITDA as a measurement of its operating performance, because it assists in comparing the operating performance on a consistent basis by removing the impact of certain non-cash and non-operating items. Adjusted EBITDA reflects an additional way of viewing aspects of the operations that the Company believes, when viewed with the GAAP results and the accompanying reconciliations to corresponding GAAP financial measures, provide a more complete understanding of factors and trends affecting its business.

 

About Sapiens

Sapiens International Corporation (NASDAQ and TASE: SPNS) is a leading global provider of software solutions for the insurance industry, with an emerging focus on the broader financial services sector. We offer core, end-to-end solutions to the global general insurance, property and casualty, life, pension and annuities, and retirement markets, as well as business decision management software. We have a track record of over 30 years in delivering superior software solutions to more than 400 financial services organizations. The Sapiens team of approximately 2,500 professionals operates through our fully-owned subsidiaries in North America, the United Kingdom, EMEA and Asia Pacific. For more information: www.sapiens.com.

 

Forward Looking Statement

Some of the statements in this press release may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities and Exchange Act of 1934 and the United States Private Securities Litigation Reform Act of 1995. Words such as "will," "expects," "believes" and similar expressions are used to identify these forward-looking statements (although not all forward-looking statements include such words). These forward-looking statements, which may include, without limitation, projections regarding our future performance and financial condition, are made on the basis of management's current views and assumptions with respect to future events. Any forward-looking statement is not a guarantee of future performance and actual results could differ materially from those contained in the forward-looking statement.

 

4

 

 

These statements speak only as of the date they were made, and we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. We operate in a changing environment. New risks emerge from time to time and it is not possible for us to predict all risks that may affect us. For more information regarding these risks and uncertainties, as well as certain additional risks that we face, please refer to the Risk Factors detailed in Item 3 of Part III of our Annual Report on Form 20-F for the year ended December 31, 2016, and subsequent reports and registration statements filed from time to time with the Securities and Exchange Commission.

 

Investors and Media Contact
Yaffa Cohen-Ifrah

Chief Marketing Officer and Head of Corporate Communications

Sapiens International

U.S. Mobile: +1 201-250-9414

Mobile: +972 54-9099039

Email: yaffa.cohen-ifrah@sapiens.com

 

5

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

 

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

U.S. dollars in thousands (except per share amounts)

 

   Three months ended   Six months ended 
   June 30   June 30 
   2017   2016   2017   2016 
   (unaudited)   (unaudited)   (unaudited)   (unaudited) 
                 
Revenue   69,049    53,030    125,583    102,597 
Cost of revenue   45,740    31,781    83,128    61,388 
                     
Gross profit   23,309    21,249    42,455    41,209 
                     
Operating expenses:                    
Research and development, net   8,952    4,001    15,147    7,254 
Selling, marketing, general and administrative   17,343    10,841    31,931    21,297 
Total operating expenses   26,295    14,842    47,078    28,551 
                     
Operating income (loss)   (2,986)   6,407    (4,623)   12,658 
                     
Financial expense (income), net   709    (326)   1,147    (406)
Taxes and other expenses (income), net   (109)   1,468    58    2,926 
                     
                     
Net income (loss)   (3,586)   5,265    (5,828)   10,138 
                     
Attributable to non-controlling interest   (8)   (68)   (38)   (82)
                     
Net income (loss) attributable to Sapiens' shareholders   (3,578)   5,333    (5,790)   10,220 
                     
                     
Basic earnings per share   (0.07)   0.11    (0.12)   0.21 
                     
Diluted earnings per share   (0.07)   0.11    (0.12)   0.21 
                     
                     
Weighted average number of shares outstanding used to compute basic earnings per share (in thousands)   49,124    48,948    49,086    48,883 
                     
Weighted average number of shares outstanding used to compute diluted earnings per share (in thousands)   49,124    49,759    49,086    49,659

 

 

 

6

 

 

Summary of Non-GAAP Financial Information
U.S. dollars in thousands (except per share amounts)

 

   Three months ended   Six months ended 
   June 30   June 30 
   2017   2016   2017   2016 
   (unaudited)   (unaudited)   (unaudited)   (unaudited) 
                                 
Revenues   69,167    100%   53,030    100%   125,701    100%   102,597    100%
Gross profit   26,389    38.2%   22,726    42.9%   46,859    37.6%   44,300    43.2%
Operating profit   3,217    4.7%   7,426    14.0%   4,915    3.9%   14,774    14.4%
Net income to shareholders   1,927    2.8%   6,251    11.8%   3,111    2.5%   12,237    11.9%
Adjusted EBITDA   4,179    6.0%   8,082    15.2%   6,753    5.4%   16,037    15.6%
                                         
Basic earnings per share   0.04         0.13         0.06         0.25      
Diluted earnings per share   0.04         0.13         0.06         0.25      

 

Non-GAAP Revenues by Geographic Breakdown
U.S. dollars in thousands

 

   Q2 2017   Q1 2017   Q4 2016   Q3 2016   Q2 2016 
                     
North America   28,544    19,465    21,107    19,706    17,601 
Europe & South Africa   36,711    32,489    28,292    28,675    26,124 
APAC   3,912    4,580    7,714    8,099    9,305 
                          
Total   69,167    56,534    57,113    56,480    53,030 

 

7

 

 

Adjusted EBITDA Calculation
U.S. dollars in thousands

 

   Three months ended   Six months ended 
   June 30   June 30 
   2017   2016   2017   2016 
                 
GAAP operating profit (loss)   (2,986)   6,407    (4,623)   12,658 
                     
Non-GAAP adjustments:                    
Amortization of capitalized software   1,235    1,256    2,256    2,665 
Amortization of other intangible assets   1,727    495    2,981    1,006 
Capitalization of software development   (1,850)   (1,396)   (2,915)   (2,780)
Stock-based compensation   456    482    911    940 
Compensation related to acquisition and acquisition-related costs   617    182    2,287    285 
Restructuring and cost reduction plan   3,900    -    3,900    - 
Valuation adjustment on acquired deferred revenue and long term contract   118    -    118    - 
                     
Non-GAAP operating profit   3,217    7,426    4,915    14,774 
                     
Depreciation   962    656    1,838    1,263 
                     
Adjusted EBITDA   4,179    8,082    6,753    16,037 

 

8

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND SUBSIDIARIES

RECONCILIATION OF GAAP TO NON-GAAP RESULTS

U.S. dollars in thousands (except per share amounts)

   Three months ended   Six months ended 
   June 30   June 30 
   2016   2015   2016   2015 
GAAP revenue   69,049    53,030    125,583    102,597 
Valuation adjustment on acquired deferred revenue and long-term contract   118         118      
Non-GAAP revenue   69,167    53,030    125,701    102,597 
                     
                     
GAAP gross profit   23,309    21,249    42,455    41,209 
Revenue adjustment   118    -    118    - 
Amortization of capitalized software   1,235    1,256    2,256    2,665 
Amortization of other intangible assets   1,727    221    2,030    426 
Non-GAAP gross profit   26,389    22,726    46,859    44,300 
                     
                     
GAAP operating income (loss)   (2,986)   6,407    (4,623)   12,658 
Gross profit adjustments   3,080    1,477    4,404    3,091 
Capitalization of software development   (1,850)   (1,396)   (2,915)   (2,780)
Amortization of other intangible assets   -    274    951    580 
Stock-based compensation   456    482    911    940 
Compensation related to acquisition and acquisition-related costs   617    182    2,287    285 
Restructuring and cost reduction plan   3,900    -    3,900    - 
Non-GAAP operating income   3,217    7,426    4,915    14,774 
                     
                     
 GAAP net income (loss) attributable to Sapiens' shareholders   (3,578)   5,333    (5,790)   10,220 
 Operating income (loss) adjustments   6,203    1,019    9,538    2,116 
 Adjustment to redeemable non-controlling interest   -    37    -    103 
 Loss on sales of Marketable Securities   -    -    230    - 
 Other   (698)   (138)   (867)   (202)
 Non-GAAP net income attributable to Sapiens' shareholders   1,927    6,251    3,111    12,237 
                     
                     
 Non-GAAP basic earnings per share   0.04    0.13    0.06    0.25 
                     
 Non-GAAP diluted earnings per share   0.04    0.13    0.06    0.25 
                     
                     
Weighted average number of shares outstanding used to compute basic earnings per share (in thousands)   49,124    48,948    49,086    48,883 
Weighted average number of shares outstanding used to compute diluted earnings per share (in thousands)   49,887    49,759    49,906    49,659 

 

9

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

U.S. Dollars in thousands

   June 30,   December 31, 
   2017   2016 
   (unaudited)   (unaudited) 
         
ASSETS        
         
CURRENT ASSETS          
Cash and cash equivalents   46,416    60,908 
Trade receivables, net   50,026    34,684 
Other receivables and prepaid expenses   8,612    6,389 
Marketable securities   -    18,220 
           
Total current assets   105,054    120,201 
           
LONG-TERM ASSETS          
Marketable securities   -    17,228 
Property and equipment, net   10,435    9,807 
Severance pay fund   4,380    4,041 
Goodwill and intangible assets, net   224,570    101,951 
Other long-term assets   3,270    4,623 
Total long-term assets   242,655    137,650 
           
TOTAL ASSETS   347,709    257,851 
           
LIABILITIES AND EQUITY          
           
CURRENT LIABILITIES          
Trade payables   7,566    6,562 
Accrued expenses and other liabilities   48,344    32,049 
Deferred revenue   24,297    9,137 
Current maturities of long-term loans   8,000    - 
Total current liabilities   88,207    47,748 
           
LONG-TERM LIABILITIES          
Other long-term liabilities   23,246    9,864 
Long Term Loans   30,000    - 
Accrued severance pay   5,398    4,940 
           
Total long-term liabilities   58,644    14,804 
           
           
REDEEMABLE NON-CONTROLLING INTEREST   908    908 
           
EQUITY   199,950    194,391 
           
TOTAL LIABILITIES AND EQUITY   347,709    257,851 

 

10

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONSOLIDATED STATEMENT OF CASH FLOW
U.S. dollars in thousands

 

  

For the six months ended

June 30

 
   2017   2016 
   (unaudited)   (unaudited) 
Cash flows from operating activities:          
Net income (loss)   (5,876)   10,138 
Reconciliation of net income (loss) to net cash provided by (used in) operating activities:          
Depreciation and amortization   7,075    4,934 
Amortization of premium, accrued interest and loss on sales of marketable securities   509    (262)
Stock-based compensation related to options issued to employees   911    940 
           
Net changes in operating assets and liabilities, net of amount acquired:          
Trade receivables   (3,236)   (1,599)
Deferred tax assets   (1,662)   52 
Other operating assets   928    (980)
Trade payables   (512)   1,574 
Other operating liabilities   1,643    (50)
Deferred revenues   7,241    4,401 
Severance pay   30    (10)
           
Net cash provided by operating activities   7,051    19,138 
           
Cash flows from investing activities:          
Purchase of property and equipment   (1,102)   (2,013)
Purchase of marketable securities, net of interest received   -    (2,359)
Proceeds from sales of marketable securities   35,369    2,677 
Payments for business acquisition, net of cash acquired   (94,951)   - 
Capitalized software development costs   (2,915)   (2,780)
           
Net cash used in investing activities   (63,599)   (4,475)
           
Cash flows from financing activities:          
Proceeds from employee stock options exercised   385    686 
Payment to shareholders in respect of acquisition   -    (1,440)
Loan received net of Repayment of loan   37,974    - 
Distribution of dividend   -    (8,809)
           
Net cash provided by (used in) financing activities   38,359    (9,563)
           
Effect of exchange rate changes on cash and cash equivalents   3,697    820 
           
Increase (decrease) in cash and cash equivalents   (14,492)   5,920 
Cash and cash equivalents at the beginning of period   60,908    54,351 
           
Cash and cash equivalents at the end of period   46,416    60,271 

 

11